SB 1017 requires healthcare providers (physicians, nurse practitioners, or physician assistants) performing surgical procedures to obtain informed consent documents signed by three parties: the provider, the patient (or their legally authorized decision maker), and a witness, along with the date. The bill specifies that if a patient cannot physically sign, a witness must verify the patient's verbal consent directly to them. It defines "surgical procedure" as operations to correct deformities, repair injuries, or diagnose/treat disease. This bill directly affects healthcare facilities and providers in Arizona by standardizing consent documentation requirements for surgical care.
SB 1014 requires health insurers in Arizona to cover gender detransition procedures (if they cover gender transition procedures) starting January 1, 2027, and mandates healthcare providers performing transition procedures to agree to provide or pay for detransition care. Insurers must report monthly data on detransition claims (excluding personal identifiers) to the state department, which will compile an annual public report. State agencies must create expedited processes for changing gender markers on official documents during detransition, with implementation deadlines through 2028, though the requirement expires December 31, 2028. The bill directly affects insurers, healthcare providers, and individuals seeking gender-related medical care or documentation changes.
SB 1065 appropriates $3,640,000 from Arizona's general fund for fiscal year 2026-2027 to the "Hyperbaric Oxygen Therapy for Military Veterans Fund" established under Arizona Revised Statutes § 41-610.01. This funding directly supports military veterans who qualify for hyperbaric oxygen therapy under the existing program. The bill provides concrete financial resources for this specific healthcare service without altering eligibility rules or creating new policies. It is a straightforward funding measure for an established veterans' health benefit.
This bill (SB 1672) modifies Arizona's Medicaid program (AHCCCS) to change how coverage is provided for prescription antipsychotic drugs. It directly affects AHCCCS members aged 18+ with a serious mental illness diagnosis who need FDA-approved antipsychotic medications. The key provision prevents prior authorization delays for these drugs, except when a step therapy protocol requires documented failure to respond to two distinct antipsychotics. This protocol must be processed electronically in real-time and considers two paid claims for different preferred antipsychotics as meeting the step therapy requirement. The bill applies only to evidence-based antipsychotic drugs and does not affect generic drug use or necessary safety reviews.
SB 1120 requires hospitals, outpatient surgical centers, and other healthcare facilities performing real-time X-ray procedures (such as cardiac catheterization) to equip at least half of their relevant procedure rooms with radiation protection systems by July 1, 2027. These systems must provide shielding equivalent to a 0.25mm lead-equivalent apron and include real-time dosimetry to measure radiation exposure for staff during procedures. The bill directly affects healthcare institutions conducting interventional medical procedures involving ionizing radiation. It mandates specific technical standards for radiation protection, focusing on staff safety during common medical imaging procedures.
SB 1240 creates payments to Arizona counties based on reducing probation failures compared to historical rates. Counties earn funds equal to 50% of prison cost savings per probationer kept out of prison (excluding those convicted of dangerous crimes against children), while the state allocates 25% of savings for statewide recidivism programs. Funds must be used for evidence-based services like drug treatment, job training, and probation officer training - not to replace existing budgets. The state calculates annual probation success rates using 2007-2019 data to determine payments and requires reporting on program effectiveness.
SB 1628 requires Arizona health insurance companies to annually report detailed data on claims denials to the state department by July 1, starting in 2027. This includes the total number of denied claims, top denied services (like medical procedures or mental health care), and reasons for denials. The state department must then compile this data into a public report by October 31, making it accessible online for at least three years. The bill aims to increase transparency around insurance practices affecting healthcare providers and patients, without changing how insurers process claims directly.
SB 1621 establishes an Obesity Treatment and Prevention Advisory Council in Arizona to address healthcare gaps related to obesity. The council, composed of 10 members including legislators, health officials, patient advocates, and medical professionals, will analyze Medicaid cost savings for preventative care, evaluate policy strategies, identify system gaps, and produce public education reports. It must submit its first report by December 31, 2027, and a follow-up by 2028 to state leaders. This procedural bill creates a temporary body (repealed January 2029) focused on guiding future policy, not directly changing Medicaid coverage or treatment access.
This bill requires AHCCCS insurance companies to reimburse non-network providers for laboratory services when a member is referred by a network provider. It also prohibits prior authorization for diagnostic services and bans insurance companies from retaliating against providers who refer members to non-network options. The law aims to increase competition within Arizona's Medicaid program by preventing insurers from blocking patient access to outside providers. It directly affects AHCCCS members, contracted healthcare providers, and non-network providers offering lab and diagnostic services.
SB 1249 establishes a coordinated state program to address Alzheimer's disease and related dementias in Arizona. It designates the Department of Health Services as the lead agency responsible for developing and updating an Alzheimer's Disease State Plan by September 2027, which must assess current services, identify gaps in care, and make recommendations to improve access to care, support for caregivers, and data collection. The bill appropriates $600,000 from the state general fund for the program's implementation and requires annual stakeholder engagement sessions with people living with dementia, caregivers, and relevant organizations. The plan must be updated and submitted to state leadership every three years, with the full plan published online. This legislation directly affects people living with Alzheimer's disease or related dementias, their unpaid caregivers, and state agencies providing related health and support services.